Abbott Laboratories(CH:ABT)
CHF 91.000.00 (0.00%)
CH:ABT
Abbott Laboratories earnings date
CHF 91.00
At close:0.00 (0.00%)
Abbott Laboratories (ABT) Q4 2022 Earnings Report
2 Followers
CH:ABT Q4 2022 EPS Results
- Actual EPS
- CHF 0.86
- Consensus EPS
- CHF 0.77
- Beat/Miss
- Beat by +CHF 0.09
- One Year Ago EPS
- CHF 1.10
CH:ABT Q4 2022 Revenue Results
- Actual Revenue
- CHF 8.43B
- Expected Revenue
- CHF 8.07B
- Beat/Miss
- Beat by +CHF 355.94M
- YoY Revenue Growth
- -12.01%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 01/25/2023
- Time
- Before Open
- Conference Call
- Wednesday, January 25, 2023
CH:ABT Upcoming Earnings
Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
CH:ABT Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ABT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2026 (Q4) | 1.37- | 1.25 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 1.191.19 | 1.09 | 9.23% (+0.10) | |
| Jul 16, 2026 | 2026 (Q2) | 1.071.09 | 1.05 | 3.97% (+0.04) | |
| Apr 16, 2026 | 2026 (Q1) | 0.960.96 | 0.91 | 5.50% (+0.05) | |
| Jan 22, 2026 | 2025 (Q4) | 1.251.25 | 1.12 | 11.94% (+0.13) | |
| Oct 15, 2025 | 2025 (Q3) | 1.091.09 | 1.01 | 7.44% (+0.08) | |
| Jul 17, 2025 | 2025 (Q2) | 1.051.05 | 0.95 | 10.53% (+0.10) | |
| Apr 16, 2025 | 2025 (Q1) | 0.900.91 | 0.82 | 11.22% (+0.09) | |
| Jan 22, 2025 | 2024 (Q4) | 1.121.12 | 0.99 | 12.61% (+0.13) | |
| Oct 16, 2024 | 2024 (Q3) | 1.001.01 | 0.95 | 6.14% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


